These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 19245128)

  • 1. Idiopathic thrombocytopenic purpura.
    Palaniappan G; Jennings W
    Mo Med; 2009; 106(1):69-73. PubMed ID: 19245128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
    Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
    Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of immune thrombocytopenic purpura: a guide for clinical practice.
    Provan D
    Eur J Haematol Suppl; 2009 Mar; (71):8-12. PubMed ID: 19200302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
    Liebman HA
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood chronic immune thrombocytopenic purpura (ITP).
    Blanchette V
    Blood Rev; 2002 Mar; 16(1):23-6. PubMed ID: 11913989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab treatment for symptomatic chronic ITP.
    Tamminga RY; Bruin MC
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):714-6. PubMed ID: 16933264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults.
    George JN; Raskob GE
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):5-8. PubMed ID: 9523743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
    Glanz J; France E; Xu S; Hayes T; Hambidge S
    Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood immune thrombocytopenic purpura: diagnosis and management.
    Blanchette V; Bolton-Maggs P
    Pediatr Clin North Am; 2008 Apr; 55(2):393-420, ix. PubMed ID: 18381093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of immune thrombocytopenic purpura in pregnancy.
    Sukenik-Halevy R; Ellis MH; Fejgin MD
    Obstet Gynecol Surv; 2008 Mar; 63(3):182-8. PubMed ID: 18279544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment advances in adult immune thrombocytopenic purpura.
    Huber MR; Kumar S; Tefferi A
    Ann Hematol; 2003 Dec; 82(12):723-37. PubMed ID: 13680177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of idiopathic thrombocytopenic purpura].
    Sachs UJ
    Hamostaseologie; 2008 Feb; 28(1-2):72-6. PubMed ID: 18278166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.
    Houwerzijl EJ; Louwes H; Sluiter WJ; Smit JW; Vellenga E; de Wolf JT
    Ann Hematol; 2008 Dec; 87(12):975-83. PubMed ID: 18690441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.